Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > I’m not good at math but there are lots of math guys

<< Previous

Bullboard Posts

Next >>

Comment by BayStreetWildon Oct 07, 2022 2:14pm

134 Views

Post# 35012833

RE:RE:RE:I’m not good at math but there are lots of math guys

I hope not but I have a feeling tax loss season this year is going to be particularly brutal.

BayStreetWild wrote:

IF they could (they've never been able to since the beginning of tigris). I'd love to see how long it's going to take them to onboard another 10 hospitals. My bet is around the next financing in 12 months. I think last time it took them a whole year. They genuinely said they would be at 60% enrolment by November in their December 2021 presentation. LOL

2027-2028 finish and another 50-60 million the way things are going. Lots of salaries, vacations and trips to the cottage by that time.

hmmmmmmmm wrote: That math correlates with the roughly 1mil a month opperating costs.

But, I agree that looking backward into the Covid years isn't completely fair.

If they could deliver on their stated worst case scenario of enrolling .5 patients, per site, per month- they would reach a more respectable 7.5 patients per million.

Time for management to turn the corner and start delivering on trial promises.